Navigation Links
Breast Cancer in Men Often Underestimated and Under-treated

Male breast cancer occasionally is misdiagnosed as gynaecomastia, which affects about a third of men at some point over the course of a lifetime, thereby causing the diseae to be discovered at later stages in men than in women. "It is perhaps ironic,that tumours in men are easier to feel than they are in women, yet the disease is being discovered at a later stage in men than in women".//Thus men tend to have more advanced disease at diagnosis.
A population-based sample of over 2,500 men with breast cancer were analysed to determine the factors that have prognostic significance in men with breast cancer. Men were found to have larger tumours and more lymph-node involvement, and they were more likely to have estrogen- and progesterone-positive tumours as well as ductal and papillary histology.

Tumour stage and size had a clear prognostic significance in men, as it does in women. Tumour grade also was of prognostic importance, with multivariate 10-year disease-specific survival rates of 93%, 66% and 53% for grades I, II and III disease, respectively (P<0.0001).

Patients with progesterone-positive tumours had significantly better 10-year survival than those with progesterone-negative disease -- 81% versus 71%. Those with estrogen-positive tumours had a trend towards improved 10-year survival, but the difference was not statistically significant. It was found that over half the men with breast cancer were over age 65 at first diagnosis. "survival was similar between 1,762 men without nodal involvement and 762 men with node-positive disease." The respective median survival in these groups was 139 months and 136 months.

Breast cancer is rare in men; there were about 1,600 cases in the US in 2002, accounting for about 1% of all breast cancer cases. Thus all men should be aware that they can develop breast cancer. "A man who has a breast lump needs a full evaluation, and [a lump] shouldn't be dismissed just because [the patient] is a man and not a woman."
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: